Literature DB >> 30088225

MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA.

Hanwen Chen1, Shuming Gao2, Cai Cheng2.   

Abstract

Accumulating evidence has demonstrated that there is critical involvement of miRNAs in the initiation and progression of cancers. Here, we showed that miR-323a-3p was significantly down-regulated in osteosarcoma (OS) tissues and cell lines. Overexpression of miR-323a-3p decreased the cell viability, colon formation and induced the apoptosis of OS cells. Using bioinformatics analysis, lactate dehydrogenase A (LDHA) was predicted as one of the down-steam targets of miR-323a-3p. Highly expressed miR-323a-3p significantly decreased both the mRNA and protein levels of LDHA. Inverse correlation between the expression of LDHA and miR-323a-3p was observed in OS tissues. Consistent with the function of LDHA in glycolysis of cancer cells, overexpression of miR-323a-3p attenuated the lactate production of OS cells. These results demonstrated that miR-323a-3p suppressed the growth of OS cells via targeting LDHA and inhibited the glycolysis of OS. This study provides insight into the molecular mechanism of miR-323a-3p in regulating OS.

Entities:  

Keywords:  Glycolysis; LDHA; MiR-323a-3p; Osteosarcoma

Mesh:

Substances:

Year:  2018        PMID: 30088225     DOI: 10.1007/s13577-018-0215-0

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  40 in total

1.  Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.

Authors:  Aik T Ooi; Brigitte N Gomperts
Journal:  Clin Cancer Res       Date:  2015-04-02       Impact factor: 12.531

2.  miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.

Authors:  R L Han; F P Wang; P A Zhang; X Y Zhou; Y Li
Journal:  Neoplasma       Date:  2017       Impact factor: 2.575

3.  miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.

Authors:  Shengni Hua; Chengdong Liu; Li Liu; Dehua Wu
Journal:  Biochem Biophys Res Commun       Date:  2018-02-12       Impact factor: 3.575

4.  MicroRNA-98 Suppress Warburg Effect by Targeting HK2 in Colon Cancer Cells.

Authors:  Weimin Zhu; Yijiao Huang; Qi Pan; Pei Xiang; Nanlan Xie; Hao Yu
Journal:  Dig Dis Sci       Date:  2016-12-26       Impact factor: 3.199

5.  MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells.

Authors:  Xu Tian; Jian Zhang; Liang Yan; Jing-Ming Dong; Qiang Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 6.  miRNA dysregulation and the risk of metastasis and invasion in papillary thyroid cancer: a systematic review and meta-analysis.

Authors:  Tiantian Wang; Hao Xu; Ming Qi; Sheng Yan; Xingsong Tian
Journal:  Oncotarget       Date:  2017-03-29

7.  MicroRNA-33b inhibits cell proliferation and glycolysis by targeting hypoxia-inducible factor-1α in malignant melanoma.

Authors:  Yue Zhao; Cuiling Wu; Lina Li
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

Review 8.  Gnathic Osteosarcoma: Clinical, Radiologic, and Pathologic Review of Bone Beard Tumor.

Authors:  Abhishek Mahajan; Richa Vaish; Subhash Desai; Supreeta Arya; Nilesh Sable; Anil K D'cruz
Journal:  J Glob Oncol       Date:  2016-10-28

9.  MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis.

Authors:  Dong Cheng; Xubin Qiu; Ming Zhuang; Chenlei Zhu; Hongjun Zou; Zhiwei Liu
Journal:  Oncotarget       Date:  2017-07-05

10.  miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.

Authors:  S Santasusagna; I Moreno; A Navarro; C Muñoz; F Martinez; R Hernández; J J Castellano; M Monzo
Journal:  Clin Transl Oncol       Date:  2018-01-26       Impact factor: 3.405

View more
  14 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Shashi Anand; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Lett       Date:  2020-01-07       Impact factor: 8.679

3.  The effect of dexmedetomidine on biological behavior of osteosarcoma cells through miR-1307 expression.

Authors:  Yanping Liu; Xiaopeng Gu; Yongtao Liu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

4.  Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks.

Authors:  Rui Hu; Shan Chen; Jianxin Yan
Journal:  J Orthop Surg Res       Date:  2021-05-07       Impact factor: 2.359

Review 5.  Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy.

Authors:  Yangbo Feng; Yanlu Xiong; Tianyun Qiao; Xiaofei Li; Lintao Jia; Yong Han
Journal:  Cancer Med       Date:  2018-11-06       Impact factor: 4.452

Review 6.  Lactate in Sarcoma Microenvironment: Much More than just a Waste Product.

Authors:  Maria Letizia Taddei; Laura Pietrovito; Angela Leo; Paola Chiarugi
Journal:  Cells       Date:  2020-02-24       Impact factor: 6.600

Review 7.  MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities.

Authors:  Abraham Pedroza-Torres; Sandra L Romero-Córdoba; Montserrat Justo-Garrido; Iván Salido-Guadarrama; Rubén Rodríguez-Bautista; Sarita Montaño; Rodolfo Muñiz-Mendoza; Cristian Arriaga-Canon; Verónica Fragoso-Ontiveros; Rosa María Álvarez-Gómez; Greco Hernández; Luis A Herrera
Journal:  Front Oncol       Date:  2019-12-11       Impact factor: 6.244

8.  MiR-638 Repressed Vascular Smooth Muscle Cell Glycolysis by Targeting LDHA.

Authors:  Shiyuan Chen; Hu Chen; Chaowen Yu; Ran Lu; Tao Song; Xiaogao Wang; Wenbo Tang; Yong Gao
Journal:  Open Med (Wars)       Date:  2019-12-31

9.  MicroRNA-323a-3p Negatively Regulates NEK6 in Colon Adenocarcinoma Cells.

Authors:  Zhongshi Hong; Zhichuan Chen; Jianpeng Pan; Zesheng Shi; Chunxiao Wang; Chengzhi Qiu
Journal:  J Oncol       Date:  2022-01-19       Impact factor: 4.375

10.  Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.

Authors:  Pengfei Shi; Jiaming Zhang; Xun Li; Wenhuan Li; Hai Li; Peng Fu
Journal:  Cell Cycle       Date:  2021-06-14       Impact factor: 5.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.